Â鶹´«Ã½Ó³»­

The has named two University of Queensland studies among its

One is a project named “The scorpion king: lighting the way to defeating brain cancer”, led by of the .

The other is “Delivering Australia from neurodegeneration”, led by of the .

Â鶹´«Ã½Ó³»­ Deputy Vice-Chancellor (Research) Professor Robyn Ward said she was delighted that Â鶹´«Ã½Ó³»­ had taken a leading position in the NHMRC’s list, reflecting the University’s strong results in research rankings tables.

“I congratulate David and Helen and their research groups on winning these awards,” Professor Ward said.

“Â鶹´«Ã½Ó³»­ strives to focus its research in areas where it can have real benefits and outcomes, and these two projects very much satisfy those criteria.

“It’s fitting that these projects come from the IMB and the QBI, as these big bio-institutes at Â鶹´«Ã½Ó³»­ are real hothouses of innovation.

“Bringing together world-class researchers in highly specialist areas in these institutes is clearly reaping great benefits for medical research, and for Â鶹´«Ã½Ó³»­ and Queensland.”

NHMRC chief executive officer Professor Anne Kelso AO said the awards highlighted projects completed in the previous year that had achieved results of particular significance for the improvement of human health – “whether through advancement of knowledge or the prevention, detection or treatment of disease”.

“Each year when projects are shortlisted for this award, we are struck by the extraordinary quality and diversity of research being undertaken in Australia with NHMRC support,” Professor Kelso said.

Professor Craik’s team set out to make synthetic derivatives of a naturally occurring peptide – chlorotoxin, from the venom of a scorpion – to use for brain tumour imaging.

The work was based on a discovery by collaborator Dr Jim Olson who found attaching a dye to chlorotoxin meant it could be used to “light up” tumours. This allows surgeons to pick up small amounts of cancerous tissue during surgery, reducing the risk of a tumour reoccurring.

The research being undertaken by Dr Cooper (pictured above) aims to understand the molecular mechanisms controlling the generation of new neurons in the adult brain.

In the long-term, it is hoped that these insights will help to design therapeutic approaches to treat neurodegenerative diseases.

A comprehensive understanding of how new brain cells are generated is seen as essential in order to develop effective strategies to repair damaged brains.

More than 342,800 Australians are living with dementia, and this number is expected to rise to 400,000 in less than 10 years.

Media: Fiona Cameron, communications@uq.edu.au, +61 7 3346 7086.